ALRN

Aileron Therapeutics, Inc. ALRN

Trading inactive

Net profit

EBITDA

P/E Ratio

Capitalization

Performance

Periode ALRN RENB MGTA GRNA PSTI ALVR SYRE BLUE KRON ERYP
6M 7.65 % -60.56 % -10.43 % -57.26 % -5.66 % -44.83 % 105.19 % -42.81 % -11.13 % 31.98 %
YTD -6.22 % -81.39 % 70.63 % -73.96 % 0.00 % -5.22 % 8.70 % -42.81 % -9.29 % 128.54 %
1Y -56.04 % -73.70 % -35.82 % -92.26 % -39.76 % -43.65 % 61.75 % -73.08 % -29.60 % -23.53 %
3Y -76.24 % -93.00 % -90.60 % -96.94 % -73.54 % -91.91 % 117.97 % -95.08 % -83.27 % -88.95 %
5Y -85.31 % -95.34 % -92.28 % -96.94 % -92.54 % -98.32 % -83.15 % -99.35 % -96.75 % -92.98 %
10Y -99.02 % -97.59 % -95.18 % -96.94 % -96.89 % -98.32 % -86.39 % -99.76 % -96.75 % -96.80 %
From the beginning -99.02 % -97.59 % -95.18 % -96.94 % -99.81 % -98.32 % -86.39 % -98.57 % -96.75 % -96.80 %

Dividend